Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Oncoimmunology|November 18, 2017
Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomesYu Wang, Ying-Jun Chang, Lu Chen, et al.
Annals of Hematology|February 9, 2023
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?Pei-Hua Wu, Wen-Xuan Huo, Xiao-Dong Mo, et al.
Pediatric Transplantation|August 3, 2020
The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantationFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2019
Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell TransplantationFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
BMC Cancer|August 16, 2022
Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemiaLu Bai, Yong-Zhan Zhang, Chen-Hua Yan, et al.
Annals of Hematology|May 18, 2013
Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificityXiao-su Zhao, Chen-hua Yan, Dai-hong Liu, et al.
Clinical Transplantation|March 22, 2012
Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factorsChen-Hua Yan, Dai-Hong Liu, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2014
Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remissionChen-Hua Yan, Qian Jiang, Jing Wang, et al.
Blood|February 17, 2012
Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantationChen-Hua Yan, Dai-Hong Liu, Kai-Yan Liu, et al.
Clinical Transplantation|May 14, 2015
Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCTChen-Hua Yan, Lan-Ping Xu, Dai-hong Liu, et al.
Pageof 16